logo

HLNE

Hamilton Lane·NASDAQ
--
--(--)
--
--(--)
5.91 / 10
Netural

Fundamental health scores 5.9/10. Strengths include high inventory turnover, strong asset returns (ROA ~24.8%), robust EPS growth (46.6%), and full gross margin. Weaknesses are a negative Asset‑MV factor and modest receivables turnover. Overall, fundamentals are moderate.

Fundamental(5.91)SentimentTechnical

Analysis Checks(8/10)

Inventory turnover ratio
Value106.57
Score2/3
Weight4.50%
1M Return1.46%
Gross profit margin (%)
Value100.00
Score3/3
Weight11.59%
1M Return3.74%
Accounts receivable turnover ratio
Value23.61
Score1/3
Weight4.11%
1M Return1.33%
Rate of return on total assets (%)
Value24.82
Score3/3
Weight20.69%
1M Return5.43%
Fixed assets turnover ratio
Value20.20
Score2/3
Weight3.50%
1M Return1.15%
Annualized return on total assets (%)
Value24.82
Score3/3
Weight20.69%
1M Return5.43%
Diluted earnings per share (YoY growth rate %)
Value46.61
Score3/3
Weight16.63%
1M Return4.85%
Asset-MV
Value-1.47
Score1/3
Weight8.41%
1M Return2.70%
Inventory turnover days
Value210.83
Score3/3
Weight4.58%
1M Return1.49%
Current assets / Total assets (%)
Value17.07
Score2/3
Weight5.30%
1M Return1.81%
Is HLNE undervalued or overvalued?
  • HLNE scores 5.91/10 on fundamentals and holds a Fair valuation at present. Backed by its 16.27% ROE, 45.43% net margin, 22.64 P/E ratio, 3.99 P/B ratio, and 3.29% earnings growth, these metrics solidify its Netural investment rating.